Personalized Treatment and Management in Dermatology
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Personalized Therapy and Drug Delivery".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 48
Special Issue Editors
2. Department of Medical Biotechnology, University of Siena, 53100 Siena, Italy
Interests: clinical dermatology; autoimmune bullous diseases; inflammatory or autoinflammatory diseases; hidradenitis suppurativa; atopic dermatitis; histopathology; immunopathology; genodermatoses
Interests: clinical or molecular genetics and immunobiology of autoimmune and autoinflammatory skin disorders including, among others, hidradenitis suppurativa and pyoderma gangrenosum; genetics of infectious diseases; genodermatoses
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Personalized (or precision) medicine can be defined as a medical model whereby health interventions are tailored based on the individual characteristics of each patient. This term implies the incorporation of a wide array of “private” data, including clinical, lifestyle, genetic and biomarker information, thus going beyond the classical “signs-and-symptoms” approach. The four principles of personalized medicine are as follows: (i) prediction and prevention of the disease; (ii) precise diagnosis; (iii) personalized interventions; (iv) and participatory role of the patients in health decisions.
Dermatology has been one of the most involved fields of medicine in new technologies and precision medicine, as attested by the tremendous scientific advances during the last 20 years. The deep phenotyping of patients at different levels (from medical history to functional diagnostics, immunology/histology and omics) are revolutionizing our clinical practice, providing an opportunity to apply artificial intelligence (AI) and machine learning algorithms to this vast dataset to create prognostic/diagnostic models and predict treatment response.
The aim of this Special Issue is to gather articles and new ideas on the topic of personalized medicine in the field of immune-mediated inflammatory skin diseases and oncodermatology. Both clinical and basic research studies are to be considered to offer readers a wider perspective of the field with a focus on prognostic and/or diagnostic biomarker discovery, genetic and omic approaches, individual response to treatment, patient-related outcomes and novel machine learning algorithms.
Original research and reviews will be particularly appreciated. We look forward to your contributions to provide update progress on this topic.
Dr. Maurizio Romagnuolo
Dr. Chiara Moltrasio
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inflammatory or autoinflammatory skin diseases
- autoimmune disorders
- melanoma and non-melanoma skin cancers
- multi-omics approaches
- prognostic or diagnostic biomarkers
- pharmacogenomics
- targeted treatments
- artificial intelligence
- machine learning algorithms
